Vitrakvi (Larotrectinib Capsules) and Xulane transdermal
Determining the interaction of Vitrakvi (Larotrectinib Capsules) and Xulane transdermal and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: larotrectinib
Brand name: Vitrakvi
Synonyms: Vitrakvi
Generic Name: ethinyl estradiol / norelgestromin
Brand name: Xulane, Ortho Evra
Synonyms: Xulane (transdermal), Xulane
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Vitrakvi (Larotrectinib Capsules)-Xultophy
- Vitrakvi (Larotrectinib Capsules)-Xultophy 100/3.6
- Vitrakvi (Larotrectinib Capsules)-Xuriden
- Vitrakvi (Larotrectinib Capsules)-Xylocaine
- Vitrakvi (Larotrectinib Capsules)-Xylocaine (Cardiac)
- Vitrakvi (Larotrectinib Capsules)-Xylocaine (Lidocaine Injection Solution (Anesthetic))
- Xulane transdermal-Vitrakvi (Larotrectinib Oral Solution)
- Xulane transdermal-Vitrase
- Xulane transdermal-Vitrase injection
- Xulane transdermal-Vitravene
- Xulane transdermal-Vitron-C
- Xulane transdermal-Vituz